High Molecular Weight PVA Simulated Tissue for Neurosurgery Training

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current surgery simulators face challenges in providing realistic training for neurosurgery and cardiovascular surgery due to inaccuracies in simulating tissue types, particularly cerebral and cardiovascular tissues, and the use of adverse solvents and fillers, which can be toxic and impractical for training.

Innovation Solution

The development of enhanced simulated tissue products using polyvinyl alcohol with a molecular weight of at least 7000 vinyl alcohol units, eliminating adverse fillers like silica particles and solvents like DMSO, and employing a multi-metric approach for realistic anatomical modeling and performance evaluation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional simulation materials (silicone, rubber, low molecular weight PVA) are used, then the simulation can be manufactured, but the tissue representation is unrealistic and the texture is impaired

Engineering Contradiction:
Improvetissue representation accuracyVSAvoidmanufacturing complexity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent changes the molecular weight parameter of polyvinyl alcohol from conventional low molecular weight (less than 3,500 vinyl alcohol units) to high molecular weight (at least 7,000 vinyl alcohol units). This parameter change fundamentally alters the material's properties, enabling it to simulate cerebral tissue with realistic texture and appearance while maintaining manufacturability through the same hydrogel formulation process.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If adverse fillers (silica particles) and solvents (DMSO) are used, then the simulation structure is achieved, but toxicity and safety issues arise

Engineering Contradiction:
Improvetraining safetyVSAvoidformulation complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent removes and eliminates harmful substances (silica particles and DMSO) from the simulation material formulation. By taking out these adverse fillers and solvents, the invention achieves safe training materials without compromising the ability to form the required hydrogel structure, as the high molecular weight PVA alone provides sufficient structural integrity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent converts the challenge of achieving structure without harmful additives into a benefit by using high molecular weight PVA's inherent properties. The high molecular weight PVA provides both structural integrity and realistic tissue properties without requiring adverse fillers, turning the restriction into an advantage for safety and material quality.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Manufacturing precision

If existing simulation tools are used, then training can be conducted, but the realism is insufficient for optimal surgeon training

Engineering Contradiction:
Improveanatomical fidelityVSAvoidtraining effectiveness
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent uses a composite material system where high molecular weight polyvinyl alcohol forms the structural matrix of the simulation tissue. This composite approach, combined with appropriate crosslinking and hydrogel formation, creates a material that simultaneously achieves anatomical fidelity, realistic texture, and functional properties needed for effective surgical training.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This solution provides a more realistic and safe training environment, enabling objective evaluation of surgical skills and improved performance metrics, leading to better-trained surgeons with enhanced proficiency and reduced risks.

Implementation Method 1

a polyvinyl alcohol material having a molecular weight in a range of at least approximately 7000 vinyl alcohol units; and water

Methodology Applied
Scientific EffectHydrogel formation: Hydrogel

Data Source

PatentUS10559227B2Simulated tissue products and methods
Publication Date: 2020.02.11 SYNAPTIVE MEDICAL INC
  • US10559227B2 patent drawing
  • US10559227B2 patent drawing
  • US10559227B2 patent drawing

AI summary

Simulated tissue products and methods involving an enhanced simulated tissue product, the enhanced simulated tissue product formed from a polyvinyl alcohol material having a molecular chain length in a range of at least approximately 7000 vinyl alcohol repeat units; and water, wherein the polyvinyl alcohol material has a preferred molecular chain length in a range of at least approximately 7150 vinyl alcohol repeat units; wherein the aqueous polyvinyl alcohol solution involves an additive, and, wherein the additive involves a plurality of nanoparticles. The simulated tissue products and methods are further useful with multi-metric surgery simulator devices, systems, and methods, such as those for training surgical tasks.